Linking Biotechnologies for Human Healthcare
Recent projects of Biolink International, Inc.
Business Dev. & Business Assessment
- Antibacterial Topical (Line-extension negotiation)
- Cardiovascular/Sepsis (Partner's clinical & regulatory activities)
- CNS/Dementia(Business assessment report)
- Cerebro-vascular disease (Market analysis report)
- Cancer/Mucositis (Report for territory option decision)
- Cancer support/CINV (Business assessment report)
- Immuno cell therapy/Cancer (Business assessment report)
- Enzyme replacement therapy/pancreatitis (Market analysis report)
- Chronic anal fissure (Market entry assessment report)
- Endometriosis (Market analysis report)
Licensing to Japan
- Synthetic Bone material
- Renal disorders
- Cancer (MAbs)
- Cancer support therapy
- Movement disorder
- Dementia
- Other technology licenses
Licensing from Japan
- Urinary & Hormones
- Eye care drug candidates
- Glioma (MAb)
- Cancer
- Infection
Novel Seed Pharmaceuticals
- Fusion protein therapeutics for cancer treatment
Drug Discovery Tools
- Proteomics drug discovery platform for 'Fee for Service' operations in Japan
- Data driven drug design technology for generation of lead pharmaceuticals for pharmaceutical firms